Surovatamig, CAS [[2892667-02-4]]

Produktübersicht

• Artikelname: Surovatamig, CAS [[2892667-02-4]]
• Artikelnummer: MCE-HY-P991028
• Hersteller Artikelnummer: HY-P991028
• Alternativnummer: MCE-HY-P991028-5MG,MCE-HY-P991028-1MG,MCE-HY-P991028-25MG,MCE-HY-P991028-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: AZD0486, TNB-486

Produktbeschreibung

Surovatamig (AZD0486, TNB-486) is a fully human anti-CD19/CD3 IgG4 bispecific antibody. Surovatamig triggers T cell activation, releases cytotoxic granules, and induces T cell-dependent cellular cytotoxicity and tumor cell lysis. Surovatamig can reduces release of pro-inflammatory cytokines including IL-2, IFNgamma, TNF. Surovatamig can be used for the research of cancer, such as B cell non-Hodgkin lymphoma[1][2].

Produkteigenschaften

• Molekulargewicht: (110.46 kDa)
• Reinheit: 99.89
• CAS Nummer: [2892667-02-4]
• Target-Kategorie: CD19,CD3,IFNAR,Interleukin Related,TNF Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies